ScinoPharm Taiwan
1789.TW
0.65 USD
0.00
0.00%
s
Overview
Last close
0.65 usd
Market cap
511.31M usd
52 week high
0.89 usd
52 week low
0.51 usd
Target price
0.57 usd
Valuation
P/E
120.8824
Forward P/E
40.3226
Price/Sales
5.1367
Price/Book Value
1.6078
Enterprise Value
463.12M usd
EV/Revenue
4.6071
EV/EBITDA
21.6246
Key financials
Revenue TTM
100.52M usd
Gross Profit TTM
34.84M usd
EBITDA TTM
19.23M usd
Earnings per Share
0.01 usd
Dividend
0.01 usd
Total assets
377.77M usd
Net debt
-74.78M usd
About
ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
- Symbol1789.TW
- ExchangeTW
- IsinTW0001789006
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Chih-Hsien Lo
- HeadquarterTainan City
- Web sitehttps://www.scinopharm.com
